首页> 外文期刊>Molecular cancer research: MCR >Fos-related antigen 1 modulates malignant features of glioma cells.
【24h】

Fos-related antigen 1 modulates malignant features of glioma cells.

机译:Fos相关抗原1调节神经胶质瘤细胞的恶性特征。

获取原文
获取原文并翻译 | 示例
           

摘要

Malignant gliomas, and high-grade gliomas (HGG) in particular, are nonmetastasizing but locally infiltrating, hypervascularized brain tumors of poor prognosis. We found previously that a c-fos-inducible vascular endothelial growth factor D is ubiquitously up-regulated in HGG grade IV, glioblastoma multiforme, and that glioblastoma multiforme overexpress Fos-related antigen 1 (Fra-1) rather than the c-Fos. We have thus become interested in the role Fra-1 may play in malignant glioma progression/maintenance, because Fra-1 has the capacity to modulate transcription of a variety of target genes. In this work, we have analyzed the biological effects of ectopic Fra-1 expression or Fra-1 knockdown in malignant glioma cells. Ectopic Fra-1 induced prominent phenotypic changes in all three malignant glioma cell lines examined: H4, U-87 MG, and A-172 MG. These changes were reflected in cells becoming more elongated with larger number of cellular processes. Furthermore, Fra-1 transgene caused H4 cells, which do not form tumor xenografts, to regain tumorigenic capacity. The genotype of these cells changed too, because 50 of 1,056 genes examined became either up-regulated or down-regulated. Conversely, Fra-1 knockdown altered prominently the morphology, anchorage-independent growth, tumorigenic potential, and Fra-1 effector expression, such as vascular endothelial growth factor D, in HGG cells. For example, cells transfected with antisense fra-1 showed shorter cellular processes than the control cells that did not grow in agar, and their tumorigenic potential was significantly diminished. Thus, Fra-1 may likely play an important role in the maintenance/progression of malignant gliomas and potentially represents a new target for therapeutic interventions.
机译:恶性神经胶质瘤,尤其是高级神经胶质瘤(HGG),无转移,但局部浸润,高血管化的脑瘤预后较差。我们以前发现,在HGG IV级多形性胶质母细胞瘤中,c-fos诱导的血管内皮生长因子D普遍上调,并且多形性胶质母细胞瘤过表达Fos相关抗原1(Fra-1),而不是c-Fos。因此,我们对Fra-1在恶性神经胶质瘤的发展/维持中可能扮演的角色感兴趣,因为Fra-1具有调节多种靶基因转录的能力。在这项工作中,我们分析了异位Fra-1表达或Fra-1基因敲低在恶性神经胶质瘤细胞中的生物学效应。异位Fra-1在所检查的所有三种恶性神经胶质瘤细胞系(H4,U-87 MG和A-172 MG)中诱导显着的表型变化。这些变化反映在随着细胞数量增加而变得越来越细长的细胞中。此外,Fra-1转基因导致未形成肿瘤异种移植物的H4细胞恢复致瘤能力。这些细胞的基因型也发生了变化,因为所检查的1,056个基因中有50个变得上调或下调。相反,Fra-1敲低显着改变了HGG细胞的形态,不依赖锚定的生长,致瘤潜力和Fra-1效应子表达,例如血管内皮生长因子D。例如,与未在琼脂中生长的对照细胞相比,用反义fra-1转染的细胞显示出更短的细胞过程,其致癌潜力大大降低。因此,Fra-1可能在恶性神经胶质瘤的维持/进展中起重要作用,并可能代表治疗干预的新目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号